Last updated: March 2026
Please read this disclaimer carefully before accessing this website. By accessing or viewing this concept demonstration platform, you acknowledge that you have read, understood, and agree to the following terms.
Nomlie is a concept demonstration that illustrates how a personalised mRNA cancer vaccine platform for companion animals could potentially operate. This website is strictly for educational and illustrative purposes only. It is not a commercial product, not a medical device, and not a service available for use by veterinary professionals, pet owners, or any other party. The platform exists solely to demonstrate a concept and does not perform any real clinical, diagnostic, or therapeutic function.
Nomlie is not a veterinary product, medical device, therapeutic good, or clinical tool. It does not provide veterinary medical advice, diagnosis, treatment recommendations, or clinical decision support. Nothing on this website should be interpreted as medical guidance of any kind. If your pet requires medical attention, consult a qualified veterinarian directly.
This platform is not indicated for, and must not be used for, the purposes of drug development, pharmaceutical research, vaccine manufacturing, clinical trial design, regulatory submissions, or any activity related to the development of therapeutic products. The genomic analysis pipelines, neoantigen prediction algorithms, and vaccine design workflows shown are illustrative mockups of how such systems could theoretically function. They do not produce real, actionable, or validated results.
This platform must not be used as part of any veterinary treatment protocol, clinical workflow, or patient care plan. No data, output, prediction, analysis, or recommendation generated by or displayed on this platform should be incorporated into treatment decisions for any animal. The demonstration data shown, including case studies, neoantigen candidates, treatment responses, and monitoring data, is entirely fictitious.
The sole purpose of this platform is educational: to demonstrate how emerging technologies such as genomic sequencing, computational neoantigen prediction, and personalised mRNA vaccine design could potentially be applied to veterinary oncology. The scientific concepts referenced are based on published peer-reviewed research, but their presentation here is simplified for illustrative purposes and does not constitute a complete or accurate representation of the underlying science.
No real patient data, veterinary records, genomic sequences, tissue samples, diagnostic reports, or any other form of clinical data is collected, stored, processed, or analysed by this platform. All case data, patient profiles, monitoring metrics, neoantigen predictions, and treatment timelines displayed on this website are entirely fictitious and were created solely for demonstration purposes. Any resemblance to real animals, veterinary cases, or clinical outcomes is coincidental.
Where artificial intelligence or computational features are referenced or demonstrated, these are illustrative of how such tools could function in a hypothetical production system. AI-generated content shown on this platform may be inaccurate, incomplete, or misleading. No AI output from this platform should be relied upon for any purpose. The demonstration does not represent the actual performance, accuracy, or reliability of any real AI system.
This platform references third-party scientific tools, databases, and research publications including, but not limited to, AlphaFold, MHCflurry, NetMHCpan, and various genomic databases and peer-reviewed journals. These references are for educational context only. Nomlie is not affiliated with, endorsed by, or responsible for any of these third-party projects or publications. Their inclusion does not imply endorsement of this platform by their creators or authors.
Nomlie is not registered, approved, cleared, or evaluated by any regulatory authority in any jurisdiction, including the Australian Pesticides and Veterinary Medicines Authority (APVMA), the Therapeutic Goods Administration (TGA), the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), or any equivalent body. This platform does not comply with, and is not intended to comply with, any regulatory framework for veterinary products, medical devices, or therapeutic goods.
This concept demonstration platform is provided "as is" and "as available" without warranties of any kind, whether express, implied, or statutory. This includes, without limitation, implied warranties of merchantability, fitness for a particular purpose, accuracy, completeness, reliability, or non-infringement. No representation is made that the information, features, or functionality demonstrated on this platform are accurate, complete, current, or suitable for any purpose.
To the maximum extent permitted by applicable law, Nomlie, its creator, contributors, affiliates, and any associated parties accept no liability whatsoever for any direct, indirect, incidental, consequential, special, or punitive damages arising from or in connection with access to, use of, or reliance on this platform or any content displayed herein. This includes, but is not limited to, any damages arising from the use of demonstrated data, outputs, or concepts for any purpose, whether clinical, commercial, educational, or otherwise.
If you have questions about this disclaimer, please contact us at support@nomlie.com.